These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19545383)

  • 1. Type-1 Collagen differentially alters beta-catenin accumulation in primary Dupuytren's Disease cord and adjacent palmar fascia cells.
    Vi L; Njarlangattil A; Wu Y; Gan BS; O'Gorman DB
    BMC Musculoskelet Disord; 2009 Jun; 10():72. PubMed ID: 19545383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts.
    Satish L; Gallo PH; Baratz ME; Johnson S; Kathju S
    BMC Musculoskelet Disord; 2011 May; 12():113. PubMed ID: 21612641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren's disease and adjacent palmar fascia cells.
    Vi L; Feng L; Zhu RD; Wu Y; Satish L; Gan BS; O'Gorman DB
    Exp Cell Res; 2009 Dec; 315(20):3574-86. PubMed ID: 19619531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts.
    Zhou C; Liu F; Gallo PH; Baratz ME; Kathju S; Satish L
    BMC Musculoskelet Disord; 2016 Nov; 17(1):469. PubMed ID: 27835939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt expression is not correlated with beta-catenin dysregulation in Dupuytren's Disease.
    O'Gorman DB; Wu Y; Seney S; Zhu RD; Gan BS
    J Negat Results Biomed; 2006 Aug; 5():13. PubMed ID: 16942611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the effects of Pirfenidone on TGF-β1 stimulated non-SMAD signaling pathways in Dupuytren's disease -derived fibroblasts.
    Zhou C; Zeldin Y; Baratz ME; Kathju S; Satish L
    BMC Musculoskelet Disord; 2019 Mar; 20(1):135. PubMed ID: 30927912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a novel gene, MafB, in Dupuytren's disease.
    Lee LC; Zhang AY; Chong AK; Pham H; Longaker MT; Chang J
    J Hand Surg Am; 2006 Feb; 31(2):211-8. PubMed ID: 16473681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dupuytren's Disease Is Mediated by Insufficient TGF-β1 Release and Degradation.
    Oezel L; Wohltmann M; Gondorf N; Wille J; Güven I; Windolf J; Thelen S; Jaekel C; Grotheer V
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture.
    Qian A; Meals RA; Rajfer J; Gonzalez-Cadavid NF
    Urology; 2004 Aug; 64(2):399-404. PubMed ID: 15302515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated levels of beta-catenin and fibronectin in three-dimensional collagen cultures of Dupuytren's disease cells are regulated by tension in vitro.
    Howard JC; Varallo VM; Ross DC; Roth JH; Faber KJ; Alman B; Gan BS
    BMC Musculoskelet Disord; 2003 Jul; 4():16. PubMed ID: 12866952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
    Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
    J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transcriptional regulation of alpha-smooth muscle actin determines the contractile phenotype of Dupuytren's nodular cells.
    Verjee LS; Midwood K; Davidson D; Eastwood M; Nanchahal J
    J Cell Physiol; 2010 Sep; 224(3):681-90. PubMed ID: 20432463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblasts from phenotypically normal palmar fascia exhibit molecular profiles highly similar to fibroblasts from active disease in Dupuytren's Contracture.
    Satish L; LaFramboise WA; Johnson S; Vi L; Njarlangattil A; Raykha C; Krill-Burger JM; Gallo PH; O'Gorman DB; Gan BS; Baratz ME; Ehrlich GD; Kathju S
    BMC Med Genomics; 2012 May; 5():15. PubMed ID: 22559715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-II and IGFBP-6 regulate cellular contractility and proliferation in Dupuytren's disease.
    Raykha C; Crawford J; Gan BS; Fu P; Bach LA; O'Gorman DB
    Biochim Biophys Acta; 2013 Oct; 1832(10):1511-9. PubMed ID: 23623986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
    Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
    J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-catenin expression in Dupuytren's disease: potential role for cell-matrix interactions in modulating beta-catenin levels in vivo and in vitro.
    Varallo VM; Gan BS; Seney S; Ross DC; Roth JH; Richards RS; McFarlane RM; Alman B; Howard JC
    Oncogene; 2003 Jun; 22(24):3680-4. PubMed ID: 12802275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing an animal model of Dupuytren's disease by orthotopic transplantation of human fibroblasts into athymic rat.
    Satish L; Palmer B; Liu F; Papatheodorou L; Rigatti L; Baratz ME; Kathju S
    BMC Musculoskelet Disord; 2015 Jun; 16():138. PubMed ID: 26049932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren's contracture: a novel target for a possible future therapeutic strategy?
    Bianchi E; Taurone S; Bardella L; Signore A; Pompili E; Sessa V; Chiappetta C; Fumagalli L; Di Gioia C; Pastore FS; Scarpa S; Artico M
    Clin Sci (Lond); 2015 Oct; 129(8):711-20. PubMed ID: 26201022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease.
    Brickley-Parsons D; Glimcher MJ; Smith RJ; Albin R; Adams JP
    J Bone Joint Surg Am; 1981 Jun; 63(5):787-97. PubMed ID: 7240301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of histological patterns in clinically affected and unaffected palm regions in dupuytren's disease.
    Alfonso-Rodríguez CA; Garzón I; Garrido-Gómez J; Oliveira AC; Martín-Piedra MÁ; Scionti G; Carriel V; Hernández-Cortés P; Campos A; Alaminos M
    PLoS One; 2014; 9(11):e112457. PubMed ID: 25379672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.